Insmed (INSM) Return on Equity [ROE] (2011 - 2026)
Insmed (INSM) reported Return on Equity [ROE] of -119.72% for Q2 2026, up 33.64 percentage points from -153.36% a year earlier and up 44.26 percentage points from the prior quarter.
Powered by 
Analysis
Insmed (INSM) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Insmed posted Return on Equity [ROE] of -249.28%.
- Return on Equity [ROE] has a five-year change of -139.87 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -193.23% in FY2022 (-66.59 pp) and -126.64% in FY2021 (-17.23 pp).
- Five-year quarterly Return on Equity [ROE] spans a low of -6083.04% in Q3 2022 and a high of -81.83% in Q3 2021.
- Year over year, Return on Equity [ROE] has now increased in each of the last four quarters, with an average year-over-year change of +176.49 percentage points over the last four quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q1 2026 (a gain of 363.03 percentage points); the low point was Q3 2022 (a drop of 6001.21 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -163.98% (Q1 2026), -151.58% (Q4 2025) and -107.85% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Insmed | 24.91 Bn | 19.42 Bn | 358.27 Mn | -119.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -119.72% |
| Mar 31, 2026 | -163.98% |
| Dec 31, 2025 | -151.58% |
| Sep 30, 2025 | -107.85% |
| Jun 30, 2025 | -153.36% |
| Mar 31, 2025 | -527.00% |
| Dec 31, 2024 | -237.72% |
| Sep 30, 2024 | -331.00% |
| Mar 31, 2023 | -2,525.28% |
| Dec 31, 2022 | -1,660.75% |
| Sep 30, 2022 | -6,083.04% |
| Jun 30, 2022 | -506.83% |
| Mar 31, 2022 | -165.02% |
| Dec 31, 2021 | -94.96% |
| Sep 30, 2021 | -81.83% |
| Jun 30, 2021 | -102.31% |
| Mar 31, 2021 | -133.75% |
| Dec 31, 2020 | -92.92% |
| Sep 30, 2020 | -64.23% |
| Jun 30, 2020 | -79.04% |
API Access
Insmed Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();